Short answer: still feeling hungry on Mounjaro (tirzepatide) is common in the first weeks and on the 2.5mg starting dose. The UK product information (SmPC, section 4.8) lists a smaller appetite as a very common effect, the band for effects that may affect more than 1 in 10 people, so not everyone notices it, and not at once: steady levels of the medicine take 4 weeks of weekly doses to reach (section 5.2), and the licence raises the 2.5mg starting dose to 5mg after 4 weeks (section 4.2). Hunger that stays often has an ordinary cause, too little protein, long gaps between meals, poor sleep, or eating from habit or stress, worth fixing before anything else. Tell your pharmacist at your next order, when the dose is reviewed, and never take an extra dose, a dose early or the liquid left in a pen to make up for it.
This guide sets out what the UK product information, the NHS and the British Dietetic Association say, as of November 2026: why hunger can carry on, whether it is normal on 2.5mg or 5mg, why some people feel hungrier before the next injection, what to change first, whether a higher dose is the answer, and when hunger is a sign of something else.
Why am I still hungry on Mounjaro?
The usual reasons are the starting dose, the first month before the medicine reaches steady levels, and ordinary causes of hunger that the medicine does not remove: too little protein, long gaps between meals, poor sleep, and eating from habit, boredom or stress.
A smaller appetite is listed, not promised. The UK product information lists decreased appetite among Mounjaro's very common side effects, the band for effects that may affect more than 1 in 10 people; the patient leaflet puts it as "making you feel less hungry and experience less food cravings". The band is not a promise: the leaflet's own footnote says the effect was very common in one large type 2 diabetes heart study and common, between 1 in 100 and 1 in 10, in the type 2 diabetes trials, and it gives no figure for the weight-management trials. A very common effect is still a group finding: some people notice it quickly, some feel full sooner at meals rather than less hungry between them, and some notice little on the starting dose.
The first month is not the test. Steady-state levels of tirzepatide are reached after 4 weeks of once-weekly dosing (section 5.2). In the clinical studies the licence describes, people on tirzepatide reported less hunger than people on placebo from the first week and more fullness from the third, as group averages over 18 weeks (section 5.1). Individual results vary. On 2.5mg the medicine has not yet reached its steady level, and you are not yet on a dose the licence treats as a maintenance dose.
Ordinary hunger is still hunger. The medicine reduces appetite; it does not undo what a long gap between meals, a low-protein breakfast or a short night does. The British Dietetic Association's guide to eating on these medicines says to avoid long gaps between meals even when portions are smaller, to have protein with each meal and to get enough sleep, and the NHS Every Mind Matters sleep pages say longer-term sleep problems can affect appetite. Wanting to eat from habit, boredom or stress can feel like hunger too. The table below takes each in turn.
Is it normal to still be hungry on Mounjaro 2.5mg or 5mg?
Yes. 2.5mg is the starting dose: the UK product information says that after 4 weeks the dose should be increased to 5mg, and it names 5mg, 10mg and 15mg as the recommended maintenance doses, with further 2.5mg steps only if needed after at least 4 weeks on the current dose, up to a maximum of 15mg (section 4.2). It gives no appetite figure by dose, so nobody can tell you how hungry you should be on 2.5mg or 5mg. 5mg is the lowest maintenance dose, and some people stay on it; as the Mounjaro page puts it, not everyone needs the highest dose, and your pharmacist reviews you before each increase.

Why the slow start? The product information records that nausea, vomiting and diarrhoea were more common while the dose was being increased and eased over time (section 4.8), and the Wegovy licence says its own 16-week build-up is "to reduce the likelihood of gastrointestinal symptoms". The 4-week steps give each dose time to settle; they are not a sign that your dose is wrong. Our guides on when to increase your Mounjaro dose and the Mounjaro dosage chart cover each step.
What usually happens in the first weeks
- Day 1
Your first 2.5mg dose. The level of medicine in your blood peaks 8 to 72 hours after each injection.
- Weeks 1 to 4
2.5mg, the starting dose, once a week. Steady levels of the medicine are reached after 4 weeks of once-weekly dosing. In the studies behind the licence, hunger scores were lower than on placebo from week 1 and fullness higher from week 3, on average.
- Week 5
The licence raises the dose to 5mg, the lowest of its three maintenance doses. Your pharmacist reviews the step at your reorder.
- From week 9
Further 2.5mg steps only if needed, each after at least 4 weeks on the current dose, up to 15mg. Not everyone needs the highest dose.
- 6 months after your highest tolerated dose
The licence's review point for weight management: whether to continue is decided with you.
Does Mounjaro stop hunger completely?
No. The UK product information describes a smaller appetite, more fullness and fewer cravings, measured against placebo as group averages, not an end to hunger, and the medicine is licensed alongside a reduced-calorie diet and more activity. Feeling hungry before a meal is normal on treatment.
What the studies behind the licence measured (section 5.1): how hungry and how full people said they felt, on rating scales; how much they ate at a free-choice lunch and dinner; and cravings for fatty, sweet and starchy foods, each compared with placebo, the meal and craving studies in people with obesity. Hunger, intake and cravings were lower on tirzepatide on average, and fullness higher. Individual results vary, and none of these is zero hunger.
"Food noise" is the phrase people use for strong thoughts about food going round in their minds. The British Dietetic Association's guide says it is normal to think about food, and that "Hunger, routines, feelings, stress, and past experiences can all shape how we think about food." Neither UK licence uses the term, so we do not promise what the medicine does to it. If food is always on your mind, or hunger feels out of your control, raise it with your pharmacist or GP: the BDA notes that not feeling hungry can also hide problems with disordered eating.
Our own expectations line says what the medicine does and does not do on its own:
Treatment works alongside a reduced-calorie diet and regular activity. Aim for at least 150 minutes a week. Weight loss naturally slows over time, and stopping treatment without keeping lifestyle changes commonly leads to weight regain, so we review you regularly and plan any stop together.
Not started treatment yet? Check whether it's suitable for you in a few minutes. A GPhC-registered pharmacist reviews every assessment, and if they can't approve your order, you get a full refund.
Check your eligibilityWhy am I hungrier the day before my next injection?
The UK product information does not describe appetite returning before the next dose, so we cannot tell you it is expected; what it does say is that tirzepatide has a half-life of about 5 days and reaches steady levels after 4 weeks of once-weekly dosing (section 5.2), so there is still medicine in your body on day 7.
Some people do notice their appetite picking up towards the end of the week, and our guide on why you may not be losing weight on Mounjaro keeps that as a pattern some people notice, not a fact about the medicine. Do not bring your injection forward to deal with it: the licence allows the injection day to move only if at least 3 days (72 hours) pass between two doses, and the leaflet says never to use a double dose (our guide on taking Mounjaro a day early or late has the rules in full). Plan those days instead: protein at the usual mealtimes, fluids and an early night, as the next section sets out. If the pattern is strong every week, tell your pharmacist at your next order, when the dose is reviewed.
What can you do if you are still hungry on Mounjaro?
Start with what you eat and when: protein at every meal, no long gaps between meals, fluids and fibre, and enough sleep; then tell your pharmacist at your next order.
| What may be behind it | What the sources say | What to try |
|---|---|---|
| Too little protein | The BDA's guide: aim to eat protein with each meal, and if a meal feels too big, start with the protein. | Protein at all three meals, eaten first. Our what-to-eat guide works to 80 to 120g a day from the 2025 joint advisory; with kidney disease, check with your GP or pharmacist before eating more. |
| Long gaps or skipped meals | The NHS: do not skip meals, you might end up snacking more because you feel hungry. The BDA: avoid long gaps between meals, even if your portions are smaller. | Three small meals a day at regular times, even when each is small. |
| Sugary drinks and snacks | The NHS: swap sugary drinks for water and cut down on food high in sugar and fat. The BDA: limit alcohol, sugary foods and fizzy drinks. | Water or an unsweetened drink between meals (the BDA suggests 1.5 to 2 litres of fluid a day); fruit, vegetables, beans and wholegrains for fibre, which also helps the constipation the medicine can cause. |
| Poor sleep | NHS Every Mind Matters: longer-term sleep problems can affect your mood and appetite. The BDA lists getting enough sleep among the habits that support treatment. | A regular bedtime and wake time, time to wind down, and less caffeine late in the day. |
| Habit, boredom or stress | The BDA: hunger, routines, feelings, stress and past experiences all shape how we think about food. | Keep meals at regular times and notice whether the urge comes soon after eating. If food is always on your mind, tell your pharmacist or GP; the BDA says this may need support. |
| The starting dose, or the first month | The UK product information: steady levels after 4 weeks; 2.5mg is the starting dose, raised to 5mg after 4 weeks; further steps only if needed. | Give each dose its 4 weeks, and tell your pharmacist at your reorder, when the dose is reviewed. |
| Low blood sugar (type 2 diabetes with insulin or a sulphonylurea) | The UK product information warns of an increased risk of hypoglycaemia with these medicines; the NHS lists feeling hungry, sweating and shaking among its symptoms. | Check your blood sugar and treat it as your diabetes team has shown you; see the safety box below. |
Already a Solira patient? Message your pharmacist through your account or the app before changing anything about your dose. We can look at your dose and your meals with you.
Our guides on what to eat on Mounjaro and the Mounjaro diet plan set out meals built this way, and does Mounjaro make you tired covers the eating-too-little side.
Should you increase your Mounjaro dose if you are still hungry?
Only if your pharmacist agrees at your next order. The UK product information raises the dose in 2.5mg steps only if needed, after at least 4 weeks on the current dose, to a maximum of 15mg, and names 5mg, 10mg and 15mg as the maintenance doses (section 4.2); it does not name hunger as the reason for a step, so that judgement is made with you, weighing how your weight is moving and how you are tolerating the dose.
Your reorder suggests the next step up when your last supply has not run out yet or ran out no more than four weeks ago. After a longer break it suggests your current dose again, and after three months or more treatment restarts at the lowest dose. Every dose is still shown, with your current one marked, and you can choose to stay on it. Your pharmacist reviews the choice before anything is sent. Not everyone needs the highest dose.
What never helps: an extra dose, a double dose after a missed one, a dose brought forward to within 3 days of the last, or the liquid left in a pen after its 4 doses, which the leaflet says not to try to use (our guide on the Mounjaro "golden dose" explains why). Too much of this medicine may cause low blood sugar and sickness, and the NHS says to get help from NHS 111 if you have used more than your prescribed dose.
Already on Mounjaro with another provider? See how switching to Solira works.
When is hunger a sign of something else?
Sometimes hunger is a symptom rather than an appetite that has not settled: low blood sugar in someone with type 2 diabetes who also takes insulin or a sulphonylurea, diabetes that has not been diagnosed, or an overactive thyroid.
Low blood sugar. The UK product information warns that tirzepatide with insulin or a sulphonylurea may increase the risk of hypoglycaemia (section 4.4). The NHS lists feeling hungry, sweating, shaking, palpitations and feeling confused among its symptoms, says it is rare in people without diabetes, and says to see a GP if you do not have diabetes and get them. If you have diabetes, check your blood sugar and treat a reading below 4mmol/L as your diabetes team has shown you.
Diabetes not yet diagnosed. Hunger is not on the NHS list of type 2 diabetes symptoms, but feeling very thirsty, passing urine more than usual, feeling very tired and losing weight without trying are, and it says to see a GP if you think you may have it. Tell your pharmacist as well as your GP.
An overactive thyroid. The NHS lists weight loss despite an increased appetite among its signs, alongside palpitations, trembling, excessive sweating and difficulty sleeping, and says to see a GP, who can arrange a blood test.
Tiredness alongside hunger, often from eating too little, is covered in our guide on whether Mounjaro makes you tired; the medicine's listed side effects are in Mounjaro side effects.
Does Wegovy do the same?
Wegovy (semaglutide) also works on appetite, but its UK product information does not list a smaller appetite among its side effects, and its dose steps are different: it starts at 0.25mg and is built up over 16 weeks, through 0.5mg, 1mg and 1.7mg, to the 2.4mg maintenance dose, "to reduce the likelihood of gastrointestinal symptoms" (section 4.2), with 7.2mg only if needed, for adults with a BMI of 30 or above, after at least 4 weeks on 2.4mg, so its first 16 weeks are the build-up.
What its licence describes (section 5.1): in a phase 1 trial, people on 2.4mg took in 35% less energy at a free-choice meal than people on placebo after 20 weeks, with more fullness, less hunger and fewer cravings. Individual results vary. So the same advice holds for anyone still hungry on Wegovy: give the dose its weeks, fix protein, meal gaps and sleep first, and raise it with your pharmacist. Our Wegovy dose schedule and Wegovy side effects guides cover the rest.

